Brazilian pharma exports to GCC up 73% to reach over $7.4 million in 2012

13 May 2013

Brazil exported $7.48 million worth of pharmaceutical products to the Gulf Cooperation Council (GCC) region in 2012, increasing by over 73% compared to $4.31 million in 2011, according to figures released by the Arab Brazilian Chamber of Commerce (ABCC). The Kingdom of Saudi Arabia and the United Arab Emirates (UAE) accounted for the biggest share of the Brazilian pharmaceutical exports at 57.02% and 41.61%, respectively.

The total pharmaceutical exports to Saudi Arabia surged by 95.63% in 2012 to reach $4.26 million, according to the ABCC figures, while exports to the UAE were valued at $3.11 million, up 56.28%.

The top Brazilian pharmaceutical products that are exported to the region include antibiotics, dental products and vaccines for veterinary use. The Arabian Gulf region ranks 44th among the top export destinations of Brazilian pharmaceutical products, but the Arab Brazilian Chamber of Commerce believes this presents a huge window of opportunity for Brazilian exporters to further expand their trade activities in the region.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

More ones to watch >